AIM Vaccine Co (HKSE:06660) Accounts Receivable : HK$1,253 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is AIM Vaccine Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. AIM Vaccine Co's accounts receivables for the quarter that ended in Dec. 2024 was HK$1,253 Mil.

Accounts receivable can be measured by Days Sales Outstanding. AIM Vaccine Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 286.47.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. AIM Vaccine Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was HK$-1.98.

AIM Vaccine Co Accounts Receivable Historical Data

The historical data trend for AIM Vaccine Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AIM Vaccine Co Accounts Receivable Chart

AIM Vaccine Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Receivable

Get a 7-Day Free Trial

1,053.06

1,302.41

1,235.09

1,161.74

1,253.35

AIM Vaccine Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Receivable	Get a 7-Day Free Trial				1,235.09	1,151.09	1,161.74	1,243.22	1,253.35

AIM Vaccine Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

AIM Vaccine Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

AIM Vaccine Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1253.347	/	798.462	*	91
=	286.47

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), AIM Vaccine Co's accounts receivable are only considered to be worth 75% of book value:

AIM Vaccine Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(635.129	+	0.75 * 1253.347	+	0.5 * 493.917	-	3953.817
-	0	-	262.207)	/	1211.063
=	-1.98

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

AIM Vaccine Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of AIM Vaccine Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

AIM Vaccine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

91 Jianguo Road, 25th Floor, Building A, Chaoyang, Beijing, CHN

Website

https://www.aimbio.com

AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development to manufacturing and commercialization. The Vaccine products include Recombinant HBV Vaccines, Freeze-dried Human Rabies Vaccine, Inactivated HAV Vaccines, Group A, C, Y, and W135 MPSV, Bivalent Inactivated HFRS Vaccine, and Mumps Vaccine. It generates all of its revenues in the PRC.

Executives

Shang Hai Xun Jing Qi Ye Guan Li Zhong Xin You Xian He Huo	2201 Interest of corporation controlled by you
Xi Zang Ying Feng Shi Ye You Xian Gong Si	2101 Beneficial owner
Yang Aihua	2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Shang Yin Xing Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Shi Bei Lun Qu Guo You Zi Ben Yun Ying You Xian Gong Si	2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Kong Gu You Xian Gong Si	2101 Beneficial owner
Chang Wei	2201 Interest of corporation controlled by you
Wang Aijun	2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd.	2201 Interest of corporation controlled by you
Zhang Kuo	2201 Interest of corporation controlled by you
Zhang Chong	2201 Interest of corporation controlled by you

AIM Vaccine Co Headlines

No Headlines